Similar Articles
1211 Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma
1212 LncRNAs expression signatures of hepatocellular carcinoma revealed by microarray
1213 Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: A meta-analysis
1214 Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry
1215 Laparoscopic liver resections for hepatocellular carcinoma: Current role and limitations
1216 MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma
1217 Hepatocellular carcinoma review: Current treatment, and evidence-based medicine
1218 Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma
1219 Staging systems of hepatocellular carcinoma: A review of literature
1220 Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA